Spinal cord stimulation study for long-term chemotherapy nerve pain
Part of Brain & nervous system, Cancer, Pain clinical trials.
This trial tests whether spinal cord stimulation can reduce pain and improve quality of life in people with long-lasting nerve pain from chemotherapy (CIPN). You must already have tried at least two nerve-pain medicines and still have significant pain, and you must have had a successful spinal cord stimulator test before joining.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and were diagnosed with chemotherapy-induced nerve pain (CIPN) for over 6 months after stopping chemo
- Your lower-leg pain averages 5 or higher out of 10 at enrollment
- You have tried at least two neuropathy (nerve) pain medicines and they did not adequately control your pain
- You must have electrical testing showing a pattern of length-dependent peripheral neuropathy (a nerve-length issue)
- You completed a 10-kHz spinal cord stimulator test for CIPN and had at least a 75% pain reduction during that test
- You must have stable nerves and stable pain medicine doses, and be able to attend study visits and complete English questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a spinal cord stimulator—a device that sends mild electrical pulses to the spine—to see if it can reduce severe nerve pain that lasts more than 6 months after chemotherapy. It is for people who have tried other treatments like duloxetine but still have significant pain.
This study tests whether a small device that sends gentle electrical pulses to nerves in your leg can relieve pain caused by chemotherapy. If you have ongoing nerve pain in your legs from past chemo, this treatment might offer a new way to manage it.
This study tests whether a gentle, non-invasive brain stimulation (over the motor cortex) can help relieve pain caused by nerve damage from chemotherapy. It is for people who have completed cancer treatment at least 3 months ago and have ongoing painful neuropathy.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This trial studies whether a skin-applied, acupuncture-like electrical treatment can reduce ongoing nerve pain (chemotherapy-induced peripheral neuropathy) after breast cancer chemotherapy. It may help if your nerve symptoms have not improved after finishing chemo.
This trial is testing a sensory rehabilitation program for people who have ongoing nerve pain or numbness in their hands or feet after chemotherapy. It aims to help improve sensation and movement.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.